Glytec partners with TidalHealth to improve hospital-based clinical outcomes and insulin management

BOSTON, Jan. 14, 2025 /PRNewswire/ — Glytec, the pioneer in cloud-based diabetes and insulin management Software-as-a-Service (SaaS) technology, is proud to announce a new strategic partnership with TidalHealth, an integrated health system based in Salisbury, Maryland. This partnership will advance diabetes and glycemic management for patients, improving safety, outcomes, and overall cost and quality of care across TidalHealth.

TidalHealth, through its Information Technology team and physician leadership, has evaluated all market options and selected Glytec as their robust diabetes and insulin management solution to seamlessly integrate with its existing EMR system and improve clinical outcomes for their patients.  Glytec’s cloud-based solution was selected for its ability to seamlessly work within TidalHealth’s existing Epic electronic medical record (EMR), and for its proven ability to optimize insulin therapy, reduce variability and risk, and improve glycemic control and clinical outcomes for patients.

“We are excited to partner with Glytec to enhance our ability to deliver high-quality care to our patients,” said Angela Brittingham, DNP, MS, RN, TidalHealth’s Vice President of Patient Care Services and Chief Nursing Executive. “We have a robust Diabetes Management team, and the integration of Glytec’s insulin management system with our EMR will streamline workflows for our inpatient clinical teams and result in improvements across the continuum of care in the outpatient sector.”

TidalHealth Peninsula Regional in Salisbury, MD, and TidalHealth Nanticoke in Seaford, DE, serve as the focal points for healthcare in the region, and improving insulin management, with a direct focus on treatment plans that are customized to each patient, is a critical step in enhancing the overall quality of care they provide.

With Glytec’s FDA-cleared, EMR-integrated, software platform, TidalHealth will be able to address the challenges associated with glycemic control, reduce the risk of complications related to diabetes and insulin therapy, and improve patient outcomes by specifically tailoring each plan using data-driven best practices.

“We are thrilled to partner with TidalHealth to bring the power of insulin management to their providers and patients,” said Pat Cua, CEO of Glytec. “Our collaboration will help TidalHealth deliver superior care while optimizing workflow efficiency and cost.”

The partnership will begin with the deployment of Glucommander, with a focus on integrating the solution within the EMR system to ensure a seamless experience for healthcare providers and clinicians.

Over time, this collaboration is expected to expand as TidalHealth seeks to improve the management of additional chronic conditions and elevate patient care across the entire health system.

About Glytec
Glytec’s industry leading SaaS platform, trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing length of stay, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by over 100 patents and over 100 publications. The Glytec Glucommander® solution, with clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics, is supported by a mission-driven team dedicated to helping healthcare leaders, clinicians and patients promote health equity and improve diabetes outcomes from hospital to home. We are on a mission, join us. For more information, follow Glytec on LinkedIn, or visit www.glytec.com.

About TidalHealth

TidalHealth is a comprehensive health system based in Salisbury, Maryland, with two hospitals and a wide array of outpatient services. Dedicated to providing exceptional care to patients throughout the Delmarva Peninsula, TidalHealth focuses on quality, safety, and delivering patient-centered care. Through its commitment to innovation and improving clinical outcomes, TidalHealth continues to advance its mission of providing world-class healthcare to its community.

Media Contact:
Public Relations
GlytecPR@glytecsystems.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/glytec-partners-with-tidalhealth-to-improve-hospital-based-clinical-outcomes-and-insulin-management-302349791.html

SOURCE Glytec, LLC

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

11 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

11 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago